The ARTIC-2 project will develop the underlying technology for the surveillance of emerging pathogens around the world. ARTIC-2 will work alongside the Africa CDC, Asia Pathogen Genomics Initiative and the WHO International Pathogen Surveillance Network to ensure that processes can then be rolled out worldwide.
Genomic surveillance is a powerful tool in the fight against infectious diseases. By analysing the genetic makeup of pathogens like viruses or bacteria, scientists can track the spread of outbreaks and understand their evolution over time. This information can help public health officials predict future outbreaks, develop targeted treatments, and implement effective control measures. It also aids in tracing the source of an outbreak and understanding how it has been transmitted between different populations. Easy access to genomic sequencing will enable public health laboratories around the world to respond more quickly and effectively to outbreaks of new and emerging viruses as well as better understand the mutations that occur randomly which lead to immune evasion or increased resistance to treatments.
A key element of the ARTIC-2 programme will be the continued development of a low-cost laboratory protocols and equipment that significantly reduce the cost of sequencing. The team are focused on reducing the cost of sequencing to under £10 per sample, reducing costs by focusing on open-source methods and reducing the reliance on expensive proprietary equipment and reagents. Lower costs allow more labs to perform sequencing where it is badly needed such as in low- and middle-income countries (LMIC) and the global south.
Read the full story on the Nuffield Department of Medicine website.